The Vienna RAP Pilot Study

• Status: Completed
• Trial end date: 2012-04-01

Summary

The purpose of this study is to evaluate the safety of a daily single oral dose of sirolimus in patients with advanced autosomal dominant polycystic kidney disease.

• Phase: N/A

Details

• Lead Sponsor: Medical University of Vienna
• Treatments: Everolimus; Sirolimus